BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16567023)

  • 1. Clozapine but not haloperidol suppresses the changes in the levels of neuropeptides in MK-801-treated rat brain regions.
    Arif M; Ahmed MM; Kumabe Y; Hoshino H; Chikuma T; Kato T
    Neurochem Int; 2006 Aug; 49(3):304-11. PubMed ID: 16567023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
    Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
    Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study.
    Ossowska K; Pietraszek M; Wardas J; Dziedzicka-Wasylewska M; Nowicka D; Wolfarth S
    Pol J Pharmacol; 2002; 54(1):1-9. PubMed ID: 12020038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment.
    Ahmed MM; Arif M; Chikuma T; Kato T
    Neurochem Int; 2005 Sep; 47(4):248-59. PubMed ID: 15985312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine.
    Zuo DY; Cao Y; Zhang L; Wang HF; Wu YL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):290-5. PubMed ID: 19121361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
    Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
    Ninan I; Kulkarni SK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
    Huang XF; Tan YY; Huang X; Wang Q
    Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice.
    Ozdemir H; Ertugrul A; Basar K; Saka E
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):62-8. PubMed ID: 22640753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effect of MK-801 on the levels of neuropeptides processing enzymes in rat brain regions.
    Ahmed MM; Yamamoto M; Chikuma T; Rahman MK; Kato T
    Neurosci Res; 2003 Oct; 47(2):177-89. PubMed ID: 14512142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tryptophan depletion on the action of haloperidol in MK-801-treated rats.
    Bubeníková V; Horácek J; Kozený J; Platilová V; Závesická L; Pálenícek T; Höschl C
    Eur J Pharmacol; 2004 Oct; 502(1-2):109-16. PubMed ID: 15464096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue.
    Corbett R
    Pharmacol Biochem Behav; 1995; 51(2-3):561-4. PubMed ID: 7667388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brain.
    Schmitt A; May B; Müller B; Jatzko A; Petroianu G; Braus DF; Henn FA
    Pharmacopsychiatry; 2003 Nov; 36(6):292-6. PubMed ID: 14663653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?
    Vardigan JD; Huszar SL; McNaughton CH; Hutson PH; Uslaner JM
    Pharmacol Biochem Behav; 2010 Apr; 95(2):223-9. PubMed ID: 20122952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated alzheimer's disease model.
    Ahmed MM; Hoshino H; Chikuma T; Yamada M; Kato T
    Neuroscience; 2004; 126(3):639-49. PubMed ID: 15183513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
    Gattaz WF; Schummer B; Behrens S
    J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study.
    Robbins MJ; Critchlow HM; Lloyd A; Cilia J; Clarke JD; Bond B; Jones DN; Maycox PR
    J Psychopharmacol; 2008 Jul; 22(5):536-42. PubMed ID: 18208916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.